Murray Cod Australia (MCA) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
18 Nov, 2025Opening remarks and agenda
Chair welcomed shareholders in person and online, confirmed quorum, and opened the meeting.
AGM chaired by Brett Paton, with formal business and voting procedures outlined for shareholders and proxyholders.
Agenda included six formal resolutions, with voting conducted by poll and MUFG Corporate Markets as scrutineer.
Instructions provided for Q&A participation both in-person and online.
Financial performance review
FY25 NPAT of $8.6m, a turnaround from ($6.2m) in FY24; revenue grew 2.6% to $10.9m, constrained by fish availability now resolved.
Record biological asset value of $67.8m (+111% YoY) and headline EBITDA of $18.61m (+808%).
AUD 17 million equity raised, strengthening the balance sheet for harvest, infrastructure, and working capital.
3.1 million fish at June 30, average weight over 800g, up from 300g the previous year.
Operating cashflow remained negative due to ongoing biomass investment.
Board and executive committee updates
Board composition discussed, with recent appointment of Steven Chaur for sales and distribution expertise.
Brett Paton (Chairman), Ross Anderson (CEO/Executive Director), Mathew Ryan (Executive Director), Roger Commins (Non-executive Director), and Steven Chaur (Non-executive Director) highlighted for their expertise and roles.
Executive team includes two women; company emphasizes merit-based appointments and gender diversity in workforce.
Katherine Bryar appointed as Chief Sales and Marketing Officer, joining in January.
Latest events from Murray Cod Australia
- Revenue up 40% year-over-year, but net loss of $4.1 million driven by higher costs.MCA
H1 20268 Mar 2026 - Sales up 45% year-over-year, with expanded retail footprint and strong export growth.MCA
Q1 2026 TU27 Oct 2025 - Record profitability and a $17m capital raise position the business for premium market growth.MCA
Investor Presentation25 Sep 2025 - Record profitability and biomass growth set the stage for accelerated sales and cash generation in FY26.MCA
Investor Presentation23 Sep 2025 - FY25 saw a $8.56M profit, 808% EBITDA growth, and record asset expansion.MCA
H2 202528 Aug 2025 - Revenue up 22% and record biomass set, driven by premium pricing and export growth.MCA
H2 202413 Jun 2025 - Net profit swung to $1.33m as revenue, biological assets, and export channels expanded.MCA
H1 20255 Jun 2025